NASDAQ:WBA - Walgreens Boots Alliance Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $46.73
  • Forecasted Upside: 21.34 %
  • Number of Analysts: 8
  • Breakdown:
  • 1 Sell Ratings
  • 7 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
▼ -0.05 (-0.13%)

This chart shows the closing price for WBA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Walgreens Boots Alliance Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for WBA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for WBA

Analyst Price Target is $46.73
▲ +21.34% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Walgreens Boots Alliance in the last 3 months. The average price target is $46.73, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 21.34% upside from the last price of $38.51.

This chart shows the closing price for WBA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 8 contributing investment analysts is to hold stock in Walgreens Boots Alliance. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 13 hold ratings
  • 3 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 10 hold ratings
  • 3 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 13 hold ratings
  • 3 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 10 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 1 buy ratings
  • 10 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 0 buy ratings
  • 10 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 0 buy ratings
  • 9 hold ratings
  • 1 sell ratings
  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 1 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 7 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/5/2022Royal Bank of CanadaLower Price TargetSector Perform$46.00 ➝ $42.00N/A
7/1/2022Deutsche Bank AktiengesellschaftLower Price TargetHold$46.00 ➝ $44.00Low
7/1/2022Truist FinancialLower Price TargetHold$50.00 ➝ $42.00Low
7/1/2022Credit Suisse GroupLower Price TargetNeutral$52.00 ➝ $43.00Low
6/24/2022BarclaysLower Price TargetEqual Weight$50.00 ➝ $45.00Low
6/9/2022CowenLower Price Target$49.00Low
6/2/2022Morgan StanleyLower Price TargetUnderweight$50.00 ➝ $43.00Medium
4/12/2022CowenLower Price Target$55.00 ➝ $50.00Low
4/12/2022CowenLower Price Target$55.00 ➝ $50.00Low
4/5/2022Deutsche Bank AktiengesellschaftLower Price TargetHold$52.00 ➝ $46.00N/A
4/5/2022UBS GroupLower Price TargetNeutral$52.00 ➝ $49.00N/A
4/1/2022BarclaysLower Price TargetEqual Weight$54.00 ➝ $50.00High
4/1/2022Truist FinancialLower Price TargetHold$58.00 ➝ $50.00High
4/1/2022Royal Bank of CanadaLower Price TargetSector Perform$52.00 ➝ $46.00High
4/1/2022Robert W. BairdDowngradeOutperform ➝ Neutral$70.00 ➝ $51.00High
1/10/2022MizuhoBoost Price Target$51.00 ➝ $56.00Low
12/22/2021UBS GroupBoost Price TargetNeutral$50.00 ➝ $52.00Medium
12/16/2021Morgan StanleyDowngradeEqual Weight ➝ Underweight$56.00 ➝ $49.00Low
10/15/2021Truist FinancialBoost Price TargetHold$52.00 ➝ $56.00High
9/24/2021Credit Suisse GroupReiterated RatingHold$48.00Medium
9/3/2021Robert W. BairdReiterated RatingBuy$68.00Low
7/6/2021BarclaysLower Price TargetEqual Weight$55.00 ➝ $53.00Low
7/2/2021Evercore ISIReiterated RatingHold$52.00Low
7/2/2021Wolfe ResearchReiterated RatingHold$57.00Medium
7/2/2021Truist FinancialLower Price TargetHold ➝ Hold$58.00 ➝ $52.00Low
7/2/2021Deutsche Bank AktiengesellschaftLower Price TargetHold$55.00 ➝ $52.00High
7/2/2021Credit Suisse GroupLower Price TargetNeutral$50.00 ➝ $48.00High
7/2/2021Robert W. BairdLower Price TargetPositive ➝ Outperform$72.00 ➝ $68.00High
6/29/2021Credit Suisse GroupReiterated RatingHold$50.00Low
6/14/2021Robert W. BairdReiterated RatingBuyMedium
6/9/2021Deutsche Bank AktiengesellschaftReiterated RatingHoldMedium
5/19/2021Robert W. BairdReiterated RatingBuyLow
5/12/2021MizuhoBoost Price TargetPositive ➝ Neutral$47.00 ➝ $55.00High
4/14/2021Morgan StanleyBoost Price TargetEqual Weight$52.00 ➝ $60.00Low
4/5/2021BarclaysBoost Price TargetEqual Weight$47.00 ➝ $55.00High
4/1/2021Royal Bank of CanadaBoost Price Target$44.00 ➝ $52.00Low
4/1/2021Truist FinancialBoost Price Target$50.00 ➝ $58.00Low
4/1/2021Credit Suisse GroupBoost Price TargetNeutral$46.00 ➝ $50.00Low
3/30/2021Morgan StanleyBoost Price TargetEqual Weight$40.00 ➝ $52.00Low
3/29/2021CowenBoost Price TargetMarket Perform$41.00 ➝ $53.00Low
3/25/2021Deutsche Bank AktiengesellschaftBoost Price TargetHold$49.00 ➝ $55.00Medium
1/27/2021Deutsche Bank AktiengesellschaftBoost Price TargetHold$44.00 ➝ $49.00Medium
1/11/2021GuggenheimUpgradeNeutral ➝ Buy$55.00High
1/11/2021MizuhoBoost Price TargetPositive ➝ Neutral$37.00 ➝ $47.00High
1/11/2021Robert W. BairdUpgradeNeutral ➝ Outperform$41.00 ➝ $55.00High
1/8/2021Truist FinancialBoost Price Target$44.00 ➝ $48.00Medium
1/8/2021BarclaysBoost Price TargetEqual Weight$40.00 ➝ $47.00Low
1/8/2021Deutsche Bank AktiengesellschaftBoost Price TargetHold$41.00 ➝ $44.00Low
1/7/2021Credit Suisse GroupInitiated CoverageNeutral$42.00Low
1/5/2021Truist FinancialBoost Price Target$40.00 ➝ $44.00N/A
10/16/2020CitigroupLower Price TargetNeutral$43.00 ➝ $40.00Low
10/8/2020BarclaysLower Price TargetEqual Weight$45.00 ➝ $40.00Medium
10/7/2020Bank of AmericaReiterated RatingSell$37.00Medium
10/6/2020The Goldman Sachs GroupLower Price TargetSell$37.00 ➝ $33.00Medium
9/11/2020MizuhoLower Price TargetNeutral$43.00 ➝ $37.00Low
9/7/2020Raymond JamesReiterated RatingHoldMedium
9/3/2020Morgan StanleyLower Price TargetEqual Weight$45.00 ➝ $40.00Low
9/2/2020Royal Bank of CanadaLower Price TargetSector Perform$45.00 ➝ $38.00Low
8/27/2020Credit Suisse GroupLower Price TargetNeutral$45.00 ➝ $42.00Medium
7/21/2020MizuhoLower Price TargetNeutral$48.00 ➝ $43.00Medium
7/10/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$43.00 ➝ $38.00Medium
7/10/2020Bank of AmericaLower Price TargetUnderperform$43.00 ➝ $40.00Medium
7/10/2020SunTrust BanksLower Price TargetHold$42.00 ➝ $40.00High
7/10/2020Royal Bank of CanadaLower Price TargetSector Perform$48.00 ➝ $45.00High
7/10/2020Credit Suisse GroupInitiated CoverageHold$50.00 ➝ $45.00High
7/10/2020BarclaysLower Price TargetEqual Weight$50.00 ➝ $45.00High
7/10/2020CitigroupLower Price TargetNeutral$48.00 ➝ $43.00High
7/2/2020Morgan StanleyLower Price TargetEqual Weight$49.00 ➝ $45.00High
6/4/2020MizuhoLower Price TargetOutperform ➝ Neutral$53.00 ➝ $48.00Medium
5/19/2020CowenLower Price TargetNeutral ➝ Market Perform$54.00 ➝ $48.00Low
4/6/2020UBS GroupUpgradeSell ➝ Neutral$49.00 ➝ $44.00High
4/3/2020JPMorgan Chase & Co.Lower Price TargetNeutral$62.00 ➝ $56.00Medium
4/3/2020SunTrust BanksLower Price TargetPositive ➝ Hold$58.00 ➝ $42.00Low
4/3/2020Credit Suisse GroupLower Price TargetNeutral$60.00 ➝ $50.00Low
4/3/2020Royal Bank of CanadaLower Price TargetSector Perform$57.00 ➝ $48.00Medium
4/3/2020BarclaysLower Price TargetEqual Weight$60.00 ➝ $50.00Medium
4/3/2020Deutsche Bank AktiengesellschaftUpgradeSell ➝ Hold$51.00 ➝ $43.00Low
4/2/2020Wells Fargo & CompanyReiterated RatingHoldLow
4/1/2020Credit Suisse GroupLower Price TargetNeutral$60.00 ➝ $50.00High
2/10/2020CowenLower Price TargetMarket Perform$60.00 ➝ $54.00Low
1/9/2020MizuhoReiterated RatingHold$59.00Low
1/2/2020Bank of AmericaReiterated RatingSell$50.00Low
12/18/2019SunTrust BanksBoost Price TargetHold$58.00 ➝ $60.00Low
12/11/2019Wells Fargo & CompanyDowngradeOverweight ➝ Equal WeightLow
12/9/2019Wells Fargo & CompanyReiterated RatingOutperform ➝ Market Perform$65.00 ➝ $61.00Low
10/30/2019Pivotal ResearchLower Price TargetHold$60.00 ➝ $55.00Low
10/23/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$73.00 ➝ $63.00Low
10/3/2019Bank of AmericaLower Price TargetUnderperform$51.00 ➝ $50.00Low
9/27/2019Royal Bank of CanadaDowngradeHold$59.00Medium
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageSellLow
9/9/2019Cleveland ResearchReiterated RatingHoldHigh
8/23/2019Morgan StanleyLower Price TargetEqual Weight$61.00 ➝ $58.00High
6/28/2019JPMorgan Chase & Co.Lower Price TargetOverweight$74.00 ➝ $73.00Low
6/3/2019Bank of AmericaLower Price TargetUnderperform$53.00 ➝ $51.00Medium
5/14/2019Morgan StanleySet Price TargetHold$61.00Low
4/18/2019GuggenheimInitiated CoverageNeutral ➝ Neutral$59.00Low
4/3/2019Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$67.00 ➝ $61.00Low
4/3/2019SunTrust BanksBoost Price TargetHold$58.00Low
4/3/2019CitigroupLower Price TargetNeutral ➝ Neutral$76.00 ➝ $60.00Low
4/3/2019UBS GroupLower Price TargetSell ➝ Sell$60.00 ➝ $49.00Low
4/3/2019Pivotal ResearchLower Price TargetHold$70.00 ➝ $60.00High
4/3/2019Wells Fargo & CompanyLower Price TargetOutperform$75.00 ➝ $65.00High
4/3/2019BarclaysLower Price TargetEqual Weight ➝ Equal Weight$78.00 ➝ $60.00High
4/3/2019Loop CapitalDowngradeBuy ➝ Hold$77.00 ➝ $60.00High
3/31/2019CowenReiterated RatingHold$66.00Low
3/28/2019MizuhoSet Price TargetHold$67.00Low
3/27/2019Loop CapitalLower Price TargetBuy$77.00Low
3/8/2019Bank of AmericaReiterated RatingUnderperform ➝ Underperform$69.00 ➝ $62.00Low
3/5/2019Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$77.00 ➝ $67.00High
3/4/2019UBS GroupLower Price TargetSell ➝ Sell$70.00 ➝ $65.00High
3/1/2019Robert W. BairdLower Price TargetNeutral ➝ Neutral$70.00 ➝ $67.00Medium
1/23/2019Loop CapitalSet Price TargetBuy$82.00Low
1/17/2019UBS GroupInitiated CoverageSell ➝ Sell$70.00Low
12/21/2018Robert W. BairdLower Price TargetNeutral ➝ Neutral$71.00 ➝ $70.00High
12/20/2018Needham & Company LLCUpgradeBuy$94.00Low
12/20/2018Loop CapitalSet Price TargetBuy$82.00High
12/19/2018Wolfe ResearchReiterated RatingPeer Perform ➝ Peer PerformHigh
12/14/2018The Goldman Sachs GroupDowngradeNeutral ➝ SellHigh
12/3/2018Morgan StanleyBoost Price TargetEqual Weight ➝ Equal Weight$55.00 ➝ $77.00Medium
10/15/2018Pivotal ResearchBoost Price TargetHold ➝ Hold$60.00 ➝ $72.00Medium
10/12/2018BarclaysBoost Price TargetEqual Weight$77.00 ➝ $80.00Medium
10/12/2018Robert W. BairdBoost Price TargetNeutral$69.00 ➝ $71.00Medium
10/12/2018CitigroupBoost Price TargetNeutral$69.00 ➝ $76.00Medium
10/12/2018SunTrust BanksBoost Price TargetHold$75.00High
10/12/2018Loop CapitalBoost Price TargetBuy$80.00 ➝ $82.00High
10/8/2018JPMorgan Chase & Co.Boost Price TargetOverweight ➝ Overweight$83.00 ➝ $91.00High
10/8/2018Royal Bank of CanadaSet Price TargetOutperform ➝ Outperform$68.00 ➝ $82.00High
9/11/2018Robert W. BairdBoost Price TargetNeutral ➝ Neutral$64.00 ➝ $69.00Low
7/23/2018CowenDowngradeOutperform ➝ Market Perform$104.00Low
7/9/2018CitigroupDowngradeBuy ➝ Neutral$69.00Low
7/2/2018Pivotal ResearchLower Price TargetHold$70.00 ➝ $60.00Low
7/2/2018MizuhoDowngradeBuy ➝ Neutral$64.00Medium
6/29/2018Royal Bank of CanadaReiterated RatingOutperformLow
6/29/2018Loop CapitalBoost Price TargetBuy$80.00Low
6/29/2018Jefferies Financial GroupDowngradeBuy ➝ Hold$85.00 ➝ $65.00Low
6/29/2018Robert W. BairdDowngradeOutperform ➝ Neutral$80.00Low
6/28/2018Bank of AmericaDowngradeNeutral ➝ Underperform$73.00 ➝ $60.00High
5/29/2018MizuhoSet Price TargetBuy$77.00Medium
5/23/2018SVB LeerinkLower Price TargetMarket Perform ➝ Market Perform$75.00 ➝ $70.00Low
4/3/2018Jefferies Financial GroupSet Price TargetBuy$85.00Low
4/2/2018ScotiabankLower Price TargetOutperform$93.00 ➝ $91.00Low
3/29/2018Pivotal ResearchSet Price TargetHold$70.00Low
3/28/2018Royal Bank of CanadaSet Price TargetBuy$88.00High
3/23/2018Pivotal ResearchLower Price TargetHold$73.00 ➝ $69.00High
3/8/2018BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$76.00Low
2/27/2018Bank of AmericaInitiated CoverageNeutral ➝ Neutral$76.00High
2/16/2018Royal Bank of CanadaSet Price TargetBuy$94.00Low
2/13/2018Loop CapitalSet Price TargetBuy$90.00Medium
1/24/2018MizuhoSet Price TargetBuy$87.00Low
1/10/2018Needham & Company LLCReiterated RatingBuy ➝ Buy$86.00 ➝ $88.00Low
1/5/2018Pivotal ResearchSet Price TargetHold$73.00High
1/4/2018Robert W. BairdReiterated RatingBuy$82.00Medium
1/4/2018Evercore ISIInitiated CoverageOutperform ➝ Outperform$80.00High
1/3/2018Loop CapitalSet Price TargetBuy$90.00High
12/21/2017SunTrust BanksSet Price TargetHold$80.00Low
12/4/2017Deutsche Bank AktiengesellschaftInitiated CoverageHold$78.00Low
11/22/2017Needham & Company LLCLower Price TargetBuy$86.00N/A
11/2/2017CitigroupLower Price TargetBuy$95.00 ➝ $81.00N/A
11/1/2017SVB LeerinkDowngradeOutperform ➝ Market PerformN/A
10/29/2017Jefferies Financial GroupSet Price TargetBuy$93.00N/A
10/26/2017Loop CapitalSet Price TargetBuy$95.00 ➝ $90.00N/A
10/25/2017Royal Bank of CanadaReiterated RatingBuy$88.00N/A
10/24/2017MizuhoSet Price TargetBuy$94.00N/A
10/24/2017Pivotal ResearchLower Price TargetHold ➝ Hold$85.00 ➝ $73.00N/A
10/19/2017Robert W. BairdReiterated RatingOutperform$90.00 ➝ $80.00N/A
10/15/2017SunTrust BanksSet Price TargetHold$72.00N/A
10/12/2017Needham & Company LLCReiterated RatingBuy$94.00N/A
10/6/2017Morgan StanleyDowngradeOverweight ➝ Equal Weight$95.00 ➝ $85.00N/A
10/2/2017Jefferies Financial GroupReiterated RatingBuy$95.00Low
9/27/2017Raymond JamesReiterated RatingOutperform ➝ Market PerformLow
9/20/2017Jefferies Financial GroupReiterated RatingBuy$95.00Low
9/19/2017Royal Bank of CanadaInitiated CoverageOutperform ➝ Outperform$96.00Medium
9/16/2017Needham & Company LLCReiterated RatingBuy$94.00Low
9/10/2017Needham & Company LLCReiterated RatingBuy$94.00Low
9/7/2017Jefferies Financial GroupReiterated RatingBuy$95.00Low
8/24/2017Loop CapitalInitiated CoverageBuy ➝ Buy$95.00Low
8/23/2017UBS GroupReiterated RatingBuy$97.00 ➝ $96.00Low
7/17/2017Needham & Company LLCSet Price TargetBuy$94.00Low
7/13/2017Credit Suisse GroupReiterated RatingBuy$97.00Low
7/7/2017SVB LeerinkSet Price TargetBuy$90.00 ➝ $86.00Low
(Data available from 7/5/2017 forward)

News Sentiment Rating

0.39 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 16 very positive mentions
  • 14 positive mentions
  • 6 negative mentions
  • 4 very negative mentions
  • 11 very positive mentions
  • 20 positive mentions
  • 5 negative mentions
  • 7 very negative mentions
  • 19 very positive mentions
  • 55 positive mentions
  • 5 negative mentions
  • 2 very negative mentions
  • 10 very positive mentions
  • 11 positive mentions
  • 3 negative mentions
  • 1 very negative mentions
  • 12 very positive mentions
  • 33 positive mentions
  • 6 negative mentions
  • 2 very negative mentions
  • 11 very positive mentions
  • 35 positive mentions
  • 2 negative mentions
  • 5 very negative mentions
  • 10 very positive mentions
  • 10 positive mentions
  • 1 negative mentions
  • 2 very negative mentions
  • 23 very positive mentions
  • 50 positive mentions
  • 12 negative mentions
  • 4 very negative mentions

Current Sentiment

  • 23 very positive mentions
  • 50 positive mentions
  • 12 negative mentions
  • 4 very negative mentions

Recent Stories by Sentiment

Walgreens Boots Alliance logo
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Read More

Today's Range

Now: $38.51
Low: $37.71
High: $38.55

50 Day Range

MA: $42.15
Low: $37.90
High: $44.94

52 Week Range

Now: $38.51
Low: $36.97
High: $55.00


6,969,383 shs

Average Volume

7,100,393 shs

Market Capitalization

$33.26 billion

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Walgreens Boots Alliance?

The following equities research analysts have issued research reports on Walgreens Boots Alliance in the last year: Barclays PLC, Cowen Inc, Cowen Inc., Credit Suisse Group AG, Deutsche Bank Aktiengesellschaft, Mizuho, Morgan Stanley, Robert W. Baird, Royal Bank of Canada,, TheStreet, Truist Financial Co., and UBS Group AG.
View the latest analyst ratings for WBA.

What is the current price target for Walgreens Boots Alliance?

0 Wall Street analysts have set twelve-month price targets for Walgreens Boots Alliance in the last year. Their average twelve-month price target is $46.73, suggesting a possible upside of 21.3%.
View the latest price targets for WBA.

What is the current consensus analyst rating for Walgreens Boots Alliance?

Walgreens Boots Alliance currently has 1 sell rating and 7 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in WBA, but not buy more shares or sell existing shares.
View the latest ratings for WBA.

How do I contact Walgreens Boots Alliance's investor relations team?

Walgreens Boots Alliance's physical mailing address is 108 Wilmot Road, Deerfield IL, 60015. The pharmacy operator's listed phone number is (847) 315-3700 and its investor relations email address is [email protected] The official website for Walgreens Boots Alliance is Learn More about contacing Walgreens Boots Alliance investor relations.